A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Incyte Corporation
Incyte Corporation
Bristol-Myers Squibb
Pfizer
Acerta Pharma BV
Pfizer
Pfizer
Boehringer Ingelheim
Xencor, Inc.
Novartis
Novartis
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Atara Biotherapeutics
Xencor, Inc.
Servier
Servier
Spectrum Pharmaceuticals, Inc
ADC Therapeutics S.A.
Autolus Limited
Novartis
Novartis
Pharmacyclics LLC.
Amgen Research (Munich) GmbH
Takeda
Takeda
Seagen Inc.
Seagen Inc.
Amgen Research (Munich) GmbH
Progen Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Morphotek
Cellerant Therapeutics
INSYS Therapeutics Inc
Pharmacyclics LLC.
Novartis
Daiichi Sankyo
BioCryst Pharmaceuticals